# A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Finding useful health information on the Internet can be difficult, but we’re here to help. This page gathers quality information from trusted sources. You can learn more about the disease, visit handpicked websites, and find resources to help you in your daily life. Need more information? Click the menu on the left to find more!

 

B-Cell Lymphomas

Get Update

Clinical Trials

This information is provided by ClinicalTrials.gov

Search Clinical Trials
Displaying 31-40 of 564 results.
Predictive Value of a mRNA Signature and Liquid Biopsy in Diffuse Large B Cell Lymphoma
Status: Recruiting
Last Changed: Jun 09, 2020
First Received: Jun 09, 2020
Disease(s): Diffuse Large B Cell Lymphoma
Locations: Sun Yat-sen Universitiy Cancer Center, Sun Yat-Sen University,, Guangzhou, China
Mature B-Cell Lymphoma And Leukemia Study III
Status: Recruiting
Last Changed: Jun 18, 2020
First Received: Jan 12, 2010
Disease(s): Mature B-Cell Lymphoma
Intervention(s): COPAD, COP, COPD M3, CYM, COP, COPADM8, CYVE
Locations: Rady Children's Hospital San Diego, San Diego, California, United States
St. Jude Children's Research Hospital, Memphis, Tennessee, United States
Children's Cancer Hospital, Cairo, Egypt
National University Health System, Singapore, Singapore
Lenalidomide in Combination With R-GemOx in First-line Treatment of Elderly Diffuse Large B Cell Lymphoma
Status: Recruiting
Last Changed: Jun 16, 2020
First Received: Jun 16, 2020
Disease(s): Diffuse Large B Cell Lymphoma
Intervention(s): Lenalidomide
Locations: The first Affiliated Hospital Of Nanjing Medical University(JiangSu Province Hospital), Nanjing, Jiangsu, China
Design of New Personalized Therapeutic Approaches for Diffuse Large B-cell Lymphoma
Status: Recruiting
Last Changed: Apr 16, 2019
First Received: Jan 09, 2019
Disease(s): Diffuse Large B Cell Lymphoma
Intervention(s): Gut microbiota samples
Locations: Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori (I.R.S.T.), Meldola, FC, Italy
Institute Of Hematology "Seràgnoli", Bologna, Italy
CTA101 in the Treatment of Relapsed or Refractory Diffuse Large B-cell Lymphoma
Status: Not yet recruiting
Last Changed: Oct 31, 2019
First Received: Jul 19, 2019
Disease(s): Diffuse Large B-cell Lymphoma
Intervention(s): CTA101
Locations: the First Affiliated Hospital of Nanjing Medical University, Nanjing, Jiangsu, China
A Study of C-CAR066 in Subjects With r/r Diffuse Large B Cell Lymphoma Who Received CD19 CAR-T Therapy
Status: Recruiting
Last Changed: Mar 20, 2020
First Received: Mar 20, 2020
Disease(s): Diffuse Large B Cell Lymphoma
Intervention(s): C-CAR066
Locations: Institute of Hematology & Blood Diseases Hospital, Tianjin, China
A Study Comparing the Efficacy and Safety of G-CHOP Versus R-CHOP in Untreated Diffuse Large B-cell Lymphoma Patients
Status: Not yet recruiting
Last Changed: Aug 29, 2018
First Received: Aug 29, 2018
Disease(s): Diffuse Large B-Cell Lymphoma, Unspecified Site
Intervention(s): G-CHOP, R-CHOP
Study of Lenzilumab and Axicabtagene Ciloleucel in Participants With Relapsed or Refractory Large B-Cell Lymphoma
Status: Recruiting
Last Changed: Jul 31, 2020
First Received: Mar 19, 2020
Disease(s): Relapsed/Refractory Large B-cell Lymphoma
Intervention(s): Cyclophosphamide, Fludarabine, Lenzilumab, Axicabtagene Ciloleucel
Locations: Mayo Clinic, Rochester, Minnesota, United States
Columbia University Medical Center, New York, New York, United States
MD Anderson Cancer Center, Houston, Texas, United States
YY-20394 、GEMOX Treatment Diffuse Large B-cell Lymphoma Single Arm, Open, Multicentrized Phase 1b/2 Clinical Trial
Status: Not yet recruiting
Last Changed: Aug 05, 2020
First Received: Aug 05, 2020
Disease(s): Diffuse Large B Cell Lymphoma
Intervention(s): YY-20394
Dose-Reduced Consolidation Radiation Therapy in Patients With Diffuse Large B-cell Lymphoma
Status: Recruiting
Last Changed: Aug 05, 2020
First Received: Sep 24, 2018
Disease(s): Diffuse Large B Cell Lymphoma
Intervention(s): Radiation Therapy
Locations: Dana Farber Cancer Institute, Boston, Massachusetts, United States
Mayo Clinic, Rochester, Minnesota, United States
University of Rochester James P. Wilmot Cancer Institute, Rochester, New York, United States
Duke University Medical Center, Durham, North Carolina, United States
MD Anderson Cancer Center, Houston, Texas, United States
... and 6 other locations.